DNA Script extends Series B
Paris-based DNA Script, a DNA synthesis company, has raised $50 million as an extension to its Series B funding, expanding the round to $89 million.
Paris-based DNA Script, a DNA synthesis company, has raised $50 million as an extension to its Series B funding, expanding the round to $89 million.
Copyright PEI Media
Not for publication, email or dissemination